In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

NEED HELP?

Read the Frequently Asked Questions for a better use

READ MORE

 

Refine your search
Sponsor

ESC Congress 365

Your free access to ESC Congress content all year long 

The online library to view thousands of videos, slides, abstracts and reports from the world's largest cardiovascular event – anytime & without subscription!

To make the most of it watch the tutorial video or check out the FAQ!

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Daiichi Sankyo Europe GmbH.

Daiichi Sankyo Europe GmbH
Abstract Slides/e-posters Video Report Interview
 
Panel discussion and conclusions - Non-vitamin K antagonist oral anticoagulants and cardioversion: the experts talk.
Presenter: R De Caterina (Chieti,IT)
2016
more
 
Welcome and introduction - Non-vitamin K antagonist oral anticoagulants and cardioversion: the experts talk.
Presenter: R De Caterina (Chieti,IT)
2016
more
 
Summary and key messages - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.
Presenter: G Y H Lip (Birmingham,GB)
2016
more
 
Welcome and introduction: edoxaban – A practical look at clinical applications.
Presenter: R De Caterina (Chieti,IT)
2016
more
 
Balancing safety and efficacy: updates from ENGAGE AF-TIMI 48 and Hokusai-VTE.
Presenter: P Verhamme (Leuven,BE)
2016
more
 
Discussion - Balancing safety and efficacy: updates from ENGAGE AF-TIMI 48 and Hokusai-VTE.
Presenter: P Verhamme (Leuven,BE)
2016
more
 
Panel Discussion and closing remarks - Edoxaban – Engaging with the real world in atrial fibrillation.
Presenter: C Bode (Freiburg,DE), R De Caterina (Chieti,IT), RK Kreutz (Berlin,DE), C T Ruff (Boston,US), J Steffel (Zurich,CH), G Y H Lip (Birmingham,GB)
2015
more
 
What do we need to take into account when selecting among the various non-vitamin K antagonist oral anticoagulants?
Presenter: A Goette (Paderborn,DE)
2015
more
 
Which non-vitamin K antagonist oral anticoagulant for which patient - Treatment algorithms for anticoagulation in atrial fibrillation.
Presenter: G Y H Lip (Birmingham,GB)
2015
more
 
The pharmacology of edoxaban and the rationale for once daily anticoagulation.
Presenter: RK Kreutz (Berlin,DE)
2015
more

The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Daiichi Sankyo Europe GmbH